CING – cingulate inc. (US:NASDAQ)

News

Cingulate Inc. (NASDAQ: CING) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
Cingulate to Participate in Benzinga All Live Access Event
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com